Literature DB >> 1713023

Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

S Schröder1, W Palinski, G W Schmid-Schönbein.   

Abstract

Capillary occlusions are characteristic features of the early diabetic retinopathy and are presumed to initiate neovascularization. Activated leukocytes can cause microvascular occlusions and cell damage by release of cytotoxic products. To explore the role of leukocytes in capillary occlusion, nonperfusion, and neovascularization of diabetic retinopathy, a rat model was used, in which a diabetic state was induced by alloxan. Retina flat preparations were differentially stained for monocytes and granulocytes. Capillary occlusion, nonperfusion, and neovascularization were assessed microscopically in the center, midperiphery, and periphery of the retina. In contrast to control retinas, 2- to 9-month diabetic rats showed many capillary occlusions by leukocytes, especially monocytes, endothelial cell damage, extravascular macrophage accumulation, and tissue damage. The percentage of activated monocytes and granulocytes in the circulating blood of diabetic rats was greatly increased, and areas of capillary 'loss' and neovascularization in the retina coincided with sites of extravascular leukocytes. The authors' results suggest a potential role of monocytes and macrophages in the pathogenesis of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713023      PMCID: PMC1886150     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

1.  Modulation of macrophage Fc receptor expression in vitro by insulin and cyclic nucleotides.

Authors:  J Rhodes
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

2.  Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.

Authors:  R H Schwartz; A R Bianco; B S Handwerger; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

3.  Binding and degradation of insulin by human peripheral granulocytes. Demonstration of specific receptors with high affinity.

Authors:  R D Fussganger; C R Kahn; J Roth; P De Meyts
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

Review 4.  Role of granulocyte collagenase in collagen degradation.

Authors:  G S Lazarus; J R Daniels; J Lian; M C Burleigh
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

5.  N.B.T. test on monocytes of neutropenic patients.

Authors:  B H Park; W D Biggar; P L'Esperance; R A Good
Journal:  Lancet       Date:  1972-05-13       Impact factor: 79.321

6.  Ocular pathology of diabetes mellitus.

Authors:  M Yanoff
Journal:  Am J Ophthalmol       Date:  1969-01       Impact factor: 5.258

7.  Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

Authors:  B H Park; S M Fikrig; E M Smithwick
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

Review 8.  Diabetic retinopathy.

Authors:  E M Kohner; N W Oakley
Journal:  Metabolism       Date:  1975-09       Impact factor: 8.694

9.  The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1974-03-01

10.  Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro.

Authors:  C G Cochrane; B S Aikin
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  149 in total

Review 1.  Scanning laser ophthalmoscopy and fundus fluorescent leucocyte angiography.

Authors:  P Hossain
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Aspirin for diabetic retinopathy.

Authors:  Eva M Kohner
Journal:  BMJ       Date:  2003-11-08

Review 4.  Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.

Authors:  R Donnelly; I Idris; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

5.  The pathogenesis of diabetic retinopathy.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

6.  Pharmacokinetics and safety of intravitreally delivered etanercept.

Authors:  Sascha Fauser; Hubert Kalbacher; Nils Alteheld; Kan Koizumi; Tim U Krohne; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-17       Impact factor: 3.117

7.  Protein kinase C upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed calpain.

Authors:  Amanda R Smolock; Gourav Mishra; Kunie Eguchi; Satoru Eguchi; Rosario Scalia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

8.  The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis.

Authors:  Phillip S Coburn; Brandt J Wiskur; Elizabeth Christy; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

9.  Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats.

Authors:  F Mori; T Hikichi; T Nagaoka; J Takahashi; N Kitaya; A Yoshida
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

10.  Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats.

Authors:  A A Bosco; A C Lerario; R F Santos; B L Wajchenberg
Journal:  Diabetologia       Date:  2003-11-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.